Anglo-Swedish pharmaceutical giant AstraZeneca’s former R&D facilities in Södertälje, south of Stockholm, will in future house a research centre for sustainable process development and catalysis.
The government-owned SP Technical Research Institute of Sweden said this week that it plans to move into the premises.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.